Logo image of NVJP.DE

UMICORE (NVJP.DE) Stock Fundamental Analysis

FRA:NVJP - Deutsche Boerse Ag - BE0974320526 - Common Stock - Currency: EUR

8.36  +0.21 (+2.64%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NVJP. NVJP was compared to 61 industry peers in the Chemicals industry. NVJP may be in some trouble as it scores bad on both profitability and health. NVJP is valued correctly, but it does not seem to be growing. NVJP also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year NVJP was profitable.
In the past year NVJP had a positive cash flow from operations.
NVJP had positive earnings in 4 of the past 5 years.
NVJP had a positive operating cash flow in each of the past 5 years.
NVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFNVJP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

1.2 Ratios

The Return On Assets of NVJP (-15.72%) is worse than 80.33% of its industry peers.
NVJP has a worse Return On Equity (-76.36%) than 81.97% of its industry peers.
Industry RankSector Rank
ROA -15.72%
ROE -76.36%
ROIC N/A
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
NVJP.DE Yearly ROA, ROE, ROICNVJP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

NVJP has a worse Gross Margin (8.17%) than 80.33% of its industry peers.
NVJP's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for NVJP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
NVJP.DE Yearly Profit, Operating, Gross MarginsNVJP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1

2. Health

2.1 Basic Checks

NVJP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NVJP remains at a similar level compared to 1 year ago.
The number of shares outstanding for NVJP remains at a similar level compared to 5 years ago.
NVJP has a worse debt/assets ratio than last year.
NVJP.DE Yearly Shares OutstandingNVJP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
NVJP.DE Yearly Total Debt VS Total AssetsNVJP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

NVJP has an Altman-Z score of 1.62. This is a bad value and indicates that NVJP is not financially healthy and even has some risk of bankruptcy.
NVJP has a worse Altman-Z score (1.62) than 63.93% of its industry peers.
The Debt to FCF ratio of NVJP is 12.00, which is on the high side as it means it would take NVJP, 12.00 years of fcf income to pay off all of its debts.
NVJP has a Debt to FCF ratio of 12.00. This is comparable to the rest of the industry: NVJP outperforms 55.74% of its industry peers.
NVJP has a Debt/Equity ratio of 1.49. This is a high value indicating a heavy dependency on external financing.
NVJP has a worse Debt to Equity ratio (1.49) than 83.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 12
Altman-Z 1.62
ROIC/WACCN/A
WACC7.34%
NVJP.DE Yearly LT Debt VS Equity VS FCFNVJP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.28 indicates that NVJP should not have too much problems paying its short term obligations.
The Current ratio of NVJP (1.28) is worse than 73.77% of its industry peers.
NVJP has a Quick Ratio of 1.28. This is a bad value and indicates that NVJP is not financially healthy enough and could expect problems in meeting its short term obligations.
NVJP has a Quick ratio of 0.77. This is in the lower half of the industry: NVJP underperforms 77.05% of its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.77
NVJP.DE Yearly Current Assets VS Current LiabilitesNVJP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

3

3. Growth

3.1 Past

NVJP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -43.01%.
Measured over the past years, NVJP shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.85% on average per year.
Looking at the last year, NVJP shows a very negative growth in Revenue. The Revenue has decreased by -18.68% in the last year.
The Revenue has been decreasing by -3.21% on average over the past years.
EPS 1Y (TTM)-43.01%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%-35.96%
Revenue 1Y (TTM)-18.68%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-8.4%

3.2 Future

NVJP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.53% yearly.
The Revenue is expected to grow by 2.07% on average over the next years.
EPS Next Y-3.54%
EPS Next 2Y0.94%
EPS Next 3Y3.83%
EPS Next 5Y11.53%
Revenue Next Year-5.21%
Revenue Next 2Y-0.22%
Revenue Next 3Y-0.18%
Revenue Next 5Y2.07%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NVJP.DE Yearly Revenue VS EstimatesNVJP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B 25B
NVJP.DE Yearly EPS VS EstimatesNVJP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.89, which indicates a rather cheap valuation of NVJP.
Compared to the rest of the industry, the Price/Earnings ratio of NVJP indicates a rather cheap valuation: NVJP is cheaper than 95.08% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.79, NVJP is valued rather cheaply.
NVJP is valuated reasonably with a Price/Forward Earnings ratio of 8.18.
Based on the Price/Forward Earnings ratio, NVJP is valued cheaper than 93.44% of the companies in the same industry.
NVJP is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.89
Fwd PE 8.18
NVJP.DE Price Earnings VS Forward Price EarningsNVJP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of NVJP indicates a rather cheap valuation: NVJP is cheaper than 90.16% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.19
EV/EBITDA N/A
NVJP.DE Per share dataNVJP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.94%
EPS Next 3Y3.83%

7

5. Dividend

5.1 Amount

NVJP has a Yearly Dividend Yield of 4.28%, which is a nice return.
NVJP's Dividend Yield is rather good when compared to the industry average which is at 3.19. NVJP pays more dividend than 83.61% of the companies in the same industry.
NVJP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.47.
Industry RankSector Rank
Dividend Yield 4.28%

5.2 History

The dividend of NVJP has a limited annual growth rate of 0.67%.
Dividend Growth(5Y)0.67%
Div Incr Years0
Div Non Decr Years4
NVJP.DE Yearly Dividends per shareNVJP.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

NVJP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of NVJP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-13%
EPS Next 2Y0.94%
EPS Next 3Y3.83%
NVJP.DE Yearly Income VS Free CF VS DividendNVJP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

UMICORE

FRA:NVJP (4/25/2025, 7:00:00 PM)

8.36

+0.21 (+2.64%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-14 2025-02-14/bmo
Earnings (Next)08-01 2025-08-01
Inst Owners46.99%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.06B
Analysts53.33
Price Target10.93 (30.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.28%
Yearly Dividend0.8
Dividend Growth(5Y)0.67%
DP-13%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.65%
PT rev (3m)-23.01%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.62%
EPS NY rev (3m)-6.99%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-26.37%
Revenue NY rev (3m)-6.4%
Valuation
Industry RankSector Rank
PE 7.89
Fwd PE 8.18
P/S 0.14
P/FCF 7.19
P/OCF 2.37
P/B 1.06
P/tB 1.33
EV/EBITDA N/A
EPS(TTM)1.06
EY12.68%
EPS(NY)1.02
Fwd EY12.23%
FCF(TTM)1.16
FCFY13.91%
OCF(TTM)3.53
OCFY42.17%
SpS60.28
BVpS7.87
TBVpS6.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.72%
ROE -76.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.17%
FCFM 1.93%
ROA(3y)-2.04%
ROA(5y)0.46%
ROE(3y)-16.55%
ROE(5y)-4.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.61%
GM growth 5Y5.16%
F-Score2
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF 12
Debt/EBITDA N/A
Cap/Depr 204.16%
Cap/Sales 3.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 0.77
Altman-Z 1.62
F-Score2
WACC7.34%
ROIC/WACCN/A
Cap/Depr(3y)224.12%
Cap/Depr(5y)196.78%
Cap/Sales(3y)3.57%
Cap/Sales(5y)2.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.01%
EPS 3Y-27.4%
EPS 5Y-3.85%
EPS Q2Q%-35.96%
EPS Next Y-3.54%
EPS Next 2Y0.94%
EPS Next 3Y3.83%
EPS Next 5Y11.53%
Revenue 1Y (TTM)-18.68%
Revenue growth 3Y-14.84%
Revenue growth 5Y-3.21%
Sales Q2Q%-8.4%
Revenue Next Year-5.21%
Revenue Next 2Y-0.22%
Revenue Next 3Y-0.18%
Revenue Next 5Y2.07%
EBIT growth 1Y-313.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year59.52%
EBIT Next 3Y20.24%
EBIT Next 5Y16.42%
FCF growth 1Y81.43%
FCF growth 3Y-30.19%
FCF growth 5YN/A
OCF growth 1Y-16.68%
OCF growth 3Y-11.62%
OCF growth 5Y12.64%